Dr. Michiel Strijbos

Consultant Medical Oncologist, AZ Sint-Augustinus, Wilrijk, Belgium

Country

Belgium

Speciality

Oncology

Subspeciality

Genitourinary Oncology

Experience

2000 years

Languages

English, Dutch, French

Areas of expertise

Genitourinary Cancer
Liquid Biomarkers
Immunotherapy

About the expert

Dr. Michiel Strijbos is a highly accomplished Medical Oncologist and Researcher specializing in Genitourinary cancer. As the Co-founder and Chief Medical Officer at NewLeaf.ai and a Consultant Medical Oncologist at AZ Sint-Augustinus in Wilrijk, Belgium, he brings a wealth of expertise to cancer care. With a strong educational background and extensive training, he is dedicated to advancing cancer research. Proficient in clinical trials, laboratory techniques, data management, and multiple languages, Dr. Strijbos focuses on Genitourinary Cancer, Liquid Biomarkers, and Immunotherapy in his research, with publications on these topics available on the well-known research network, PubMed.

Dr. Michiel Strijbos is a highly accomplished Medical Oncologist and Researcher with extensive experience in the field of Genitourinary oncology. Currently serving as the Co-founder and Chief Medical Officer at NewLeaf.ai, as well as a Consultant Medical Oncologist at AZ Sint-Augustinus in Wilrijk, Belgium, he brings a wealth of expertise to the forefront of cancer care. Dr. Strijbos has held several key positions in prestigious healthcare institutions, including his role as Head of Medical Oncology at Need. He has also contributed significantly to various medical committees and editorial boards, demonstrating his commitment to advancing cancer research and treatment.

With a distinguished educational background that includes a PhD from Erasmus University Rotterdam and a Medical Degree obtained with honors from the same institution, Dr. Strijbos has equipped himself with a strong foundation in oncology. He has received additional training from top organizations like ECCO-ESMO-EORTC workshop in Switzerland, further enhancing his skills and knowledge in the field. Dr. Strijbos is actively involved in various committees and editorial boards, such as the European School of Oncology and ESMO Open Editorial Board for GU Malignancies, underscoring his dedication to academic excellence and advancement.

Dr. Strijbos possesses a diverse set of skills and expertise, ranging from leading clinical trials to proficiency in laboratory techniques such as flow cytometry and RT-PCR. His expertise in data management and his fluency in multiple languages further enhance his effectiveness as a researcher and practitioner. His research interests focus on Genitourinary Cancer, Liquid Biomarkers, and Immunotherapy, reflecting his commitment to exploring innovative approaches to cancer treatment. His publications on these subjects are available on PubMed, showcasing his contributions to the scientific community and his impact on advancing cancer care.

Consultant Medical Oncologist
2019 - Today
AZ Sint-Augustinus, Wilrijk, Belgium
Faculty Member
2018 - Today
European School of Oncology
Co-founder and Chief Medical Officer
2023 - Today
NewLeaf.ai
Head of Medical Oncology
2022 - 2022
Need Medical Center
Consultant Medical Oncologis
2014 - 2019
AZ Klina, Brasschaat, Belgium

ECCO-ESMO-EORTC workshop, Switzerland

ECCO-ESMO-EORTC

2013
PhD

Erasmus University Rotterdam

2009
Medical Degree

Erasmus University Rotterdam

2005
Medicine

Catholic University of Leuven

2002
Medicine

University Hasselt, Diepenbeek

2000

Editorial Board Member: ESMO Open, Cancer Treatment Communications, Frontiers of Oncology
Member, ESMO Open Editorial Board, GU Malignancies (2018)
Member, ESMO Genitourinary Faculty & Publishing Working Group (2017)
Member, EORTC Genitourinary Tract Cancer Group (2016)

Other experts inthe same specialty

Doctor Premini Mahendra

Consultant Haemato-Oncologist, Birmingham, United Kingdom